ORIGINAL ARTICLE

Postoperative Bleeding in CABG Patients: New Study in Southwest of Iran

Amanollah Heidari , Mehdi Dehghani Firoozabadi, Mohammad Ali Sheikhi

Amanollah Heidari
Assistant Professor of Cardiovascular surgery MD, Department of Cardiac surgery, Atherosclerosis Research Center and Imam Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Email: amanollahri@gmail.com

Mehdi Dehghani Firoozabadi
Assistant Professor of Cardiac Anesthesiology MD, Department of anesthesiology, Shahid Sadoughi University of Medical Sciences-Yazd, Iran

Mohammad Ali Sheikhi
Assistant Professor of Cardiovascular surgery MD, Department of Cardiac surgery, Atherosclerosis Research Center Golestan Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Online First: September 18, 2016 | Cite this Article
Heidari, A., Firoozabadi, M., Sheikhi, M. 2016. Postoperative Bleeding in CABG Patients: New Study in Southwest of Iran. Bali Medical Journal 5(3): 400-403. DOI:10.15562/bmj.v5i3.294


Background: A common complication after Coronary Artery Bypass Grafting (CABG) is postoperative bleeding, which is considered as an important problem. Objective: The aim of this study is to study only patients who have never used drugs above so that it can assess postoperative bleeding in CABG with the absence of high-risk medications related to postoperative bleeding. Method: 50 patients who were candidates for CABG surgery participated in the study. Inclusions criteria included who were candidates for CABG surgery, avoiding the use of blood-clotting drugs before surgery, avoiding the use of immunosuppressant, and the absence of an underlying medical condition such as kidney diseases. Patients with inflammatory, platelet diseases, or any coagulation disorder were excluded. All patients initially tested for hemoglobin, platelets and hemoglobin and INR. In addition to testing for hemoglobin, the amount of bleeding and packed red cell; frozen plasma and platelets were recorded. Results: Fifty patients who were candidates for elective surgery, including 33 men (66%) and 17 women (34%) were enrolled in this study. The mean patient age was 8.70+57.9years old. Test showed that mean hemoglobin level of patients before surgery was pre-operative of 1.5 + 12.4 g/dL, mean platelet was equal to 54.14 + 250.8 thousand/µL and an average international normalized ratio (INR) was equal to 0.12+1.07. The results after surgery also showed that: The total units of given packed red cell; frozen plasma and platelets were (3.14 + 1.90; 2.34 + 2.36 and 0.06 + 0.42). Also, postoperative hemoglobin was 1.30 + 10.30 g/dL, which significantly decreased compared to pre-operative hemoglobin. Bleeding in patients was observed with an average of 537.5 + 973 mL. Of course, the amount of bleeding in any patient was not caused further surgery, Conclusion: that the use of some drugs surgery can be a good way to reduce the risk of bleeding after surgery or on-use of some drugs can reduce the risk of bleeding after surgery with a minimum of morbidity and mortality. It is suggested that other researchers after designing clinical trials and using lower doses for effective drugs such as Clopidogrel and compared to control groups, or different doses of the N-acetylcysteine drug be reported more documentation to improve the bleeding after surgery.

References

SHEIKHI, Mohammad Ali; EBADI, Ahmad; RAHMANI, Hossein. Importance of further recognition of atherosclerotic patients candidate for CABG: predisposing factors for postoperative stroke. Advances in Natural and Applied Sciences, 2015, 9.3: 8-13.‏

Sheikhi, M. A., Ebadi, A., Ramezani, A., & Gholizadeh, B. (2015). From atherosclerosis to cabg. International Journal of Bioassays, 4(02), 3676-3681.‏

Soltanzadeh M, Ebad A, Pipelzadeh MR, Tabatabaei SK, Firouzabadi MD, Vasigh A, Soltanzadeh MA, Heidari A, Ramazani A, Haybar H. Gabapentin may relieve post-coronary artery bypass graft pain: a double blind randomized clinical trial. International Cardivascular Research Journal. 2011 Sep;5(3):79-82.

Mohammad Ali Sheikhi, Ahmad Ebadi, Behnam Gholizadeh and Khosrow Sharifi. EFFECTS AND RISKS OF THORACIC EPIDURAL ANESTHESIA FOR CARDIAC SURGERY. World Journal of Pharmaceutical Research.Volume 4, Issue 8, 236-251.

Adel SM, Ramezanei AA, Hydarei A, Javaherizadeh H, Behmanesh V, Amanei V. Gender-related differences of risk factors among patients undergoing coronary artery bypass graft in Ahwaz, Iran. Saudi medical journal. 2007;28(11):1686-9.

-Goa F, Yao K, Tsai C, Wang K. Predictors of health care needs in discharged patients who have undergone coronary artery bypass graft surgery. Heart Lung. 2009. 38(3):182.

-Abbaslo MR, Eghtesadi Araghi P, zafar Asodeh A. The Comparision of rekationship between preoperative bleeding time and postoperative bleeding in patients undergoing coronary artery bypass graft. JAUMS. 2004.1(4): 222-17.

-Gregory AN, Daniel TE. A Comparison of Bleeding and Transfusion in patients who undergo coronary artery bypass grafting via sternotomy with and without cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2003;17: 447-51.

-Biancari F , Mikkola R , Heikkinen J , Lahtinen J , Airaksinen KE , Juvonen T. Estimating the risk of complications related to re-exploration for bleeding after adult cardiac surgery. Eur J Cardiothoracic surgery. 2012. 41(1):50-5.

-Cohen LH. Cardiac surgical in the adult. USA: McGraw- Hill companies; 2008.

Nussmeier NA, Hauser MC, Sarwar MF, Grigore AM, Searies BE. In: Miller RD. Miller's Anesthesia. 7th ed. Philadelphia: Churchill Livingstone; 2010. p. 1889-975.

Pleym H, Wahba A, Videm V, Asberg A, Lydersen S, Bjella L, et al. Increased fibrinolysis and platelet activation in elderly patients undergoing coronary bypass surgery. Anesth Analg

;102(3):660-7.

Michalopoulos A, Tzelepis G, Dafni U, Geroulanos S. Determinants of hospital mortality after coronary artery bypass grafting. Chest 1999;115(6):1598-603.

Ranucci M, Pavesi M, Mazza E, Bertucci C, Frigiola A, Menicanti L, et al. Risk factors for renal dysfunction after coronary surgery: the role of cardiopulmonary bypass technique. Perfusion 1994;9(5):319-26.

Leal-Noval SR, Rincón-Ferrari MD, García-Curiel A, Herruzo- Avilés A, Camacho-Laraña P, Garnacho-Montero J, et al. Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery. Chest 2001;119(5):1461-8.

Vamvakas EC, Carven JH. Allogeneic blood transfusion and postoperative duration of mechanical ventilation: effects of red cell supernatant, platelet supernatant, plasma components and total transfused fluid. Vox Sang 2002;82(3):141-9.

Moshfegh K, Redondo M, Julmy F, Wuillemin WA, Gebauer MU, Haeberli A, et al. Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy. J Am Coll Cardiol 2000; 36(3): 699-705.

SHEIKHI, Mohammad Ali; EBADI, Ahmad; RAHMANI, Hossein. Sleep disorder in cardiac care units: a special look at noise and light effects. International Journal of Bioassays, 2014, 4.01: 3680-3685.‏

FIROOZABADI, Mehdi Dehghani; EBADI, Ahmad. The effect of oral N-acetylcysteine on serum creatinine in chronic kidney diseases patients under CABG surgery. Life Science Journal, 2014, 11.4s.‏

HORVATH, Keith A., et al. Blood transfusion and infection after cardiac surgery. The Annals of thoracic surgery, 2013, 95.6: 2194-2201.‏

SHEIKHI, Mohammad Ali, et al. Cardiac surgery anesthesia and systemic inflammatory response. International Journal of Bioassays, 2015, 4.02: 3648-3655.‏

Rahmani, H., Shahriary, A., Sheikhi, M. A., Ebadi, A., & Davoodzadeh, H. (2016). Applications of cardio-toxicity in breast cancer: a meta-analysis. Panminerva medica.‏

Sheikhi MA, Rahmani H. Inflammatory statuses of Non-Smoker Mustard Lung Patient candidate for Coronary artery bypass grafting Surgery.Int. J. Pharm. Res. Allied Sci., 2016, 5(3):194-195

Heidari A, Sheikhi MA, Rahmani H. Inflammatory status of Non-Smoker Sulphur Mustard exposed Patient with Cancer candidate for Coronary artery bypass grafting Surgery.Int. J. Pharm. Res. Allied Sci., 2016, 5(3):196-198

Hossein Rahmani, Iraj Javadi and Saeed Shirali. 2016. Respiratory Complications Due to Sulfur Mustard ExposureInt.J.Curr.Res.Aca.Rev. 4(6): 143-149

CHU, Michael WA, et al. Does clopidogrel increase blood loss following coronary artery bypass surgery?. The Annals of thoracic surgery, 2004, 78.5: 1536-1541.‏

WANG, Guyan, et al. N-acetylcysteine in cardiac surgery: do the benefits outweigh the risks? A meta-analytic reappraisal. Journal of cardiothoracic and vascular anesthesia, 2011, 25.2: 268-275.‏


Article Views      : 0
PDF Downloads : 0